Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Asymptomatic Follicular NHL or Relapsed Hodgkin's Disease
NCT00003849Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 1999
- Primary completion
- Feb 2005
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab in follicular lymphoma (FL), Hodgkin lymphoma (HL), sponsored by Cancer and Leukemia Group B. Started Jul 1999; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003849.